Ryan McDonald

Ryan McDonald, Associate Editorial Director for CURE®, has been with the team since February 2020 and has previously covered medical news across several specialties prior to joining MJH Life Sciences. He is a graduate of Temple University, where he studied journalism and minored in political science and history. He considers himself a craft beer snob and would like to open a brewery in the future. During his spare time, he can be found rooting for all major Philadelphia sports teams. Follow Ryan on Twitter @RMcDonald11 or email him at rmcdonald@curetoday.com.

After The Dust Settled: Retired NYC Firefighter Remembers 9/11 After Lung Cancer Journey

September 11, 2021

Podcast

A retired New York City firefighter recalls his return to the city he once served for more than three decades on the day prior to the 9/11 terrorist attacks and all that followed, including his several bouts with lung cancer years after the dust had settled.

Brukinsa Receives FDA Approval for Treatment of Waldenstrom’s Macroglobulinemia

September 01, 2021

Article

The FDA approval of Brukinsa, according to an expert from the Dana-Farber Cancer Institute, provides an important new option for targeted therapy in Waldenstrom’s macroglobulinemia.

Investigational Cancer Treatment Being Evaluated in B-Cell Malignancies

August 23, 2021

Article

Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.

Patient Recruitment Has Begun for Trial Assessing Cosela in Metastatic Bladder Cancer

August 20, 2021

Article

Preliminary results of the phase 2 trial assessing the safety and efficacy of Cosela with gemcitabine/platinum-based chemotherapy and Bavencio maintenance therapy for metastatic bladder cancer are expected to be released in the second half of 2022.

High Volume of Vitamin D Intake Linked to Decreased Early-Onset Colon Cancer Risk

August 17, 2021

Article

People who meet regular dietary recommendations and the minimum daily requirement for vitamin D intake may experience a protection against early-onset colon cancer, according to an expert from the Dana-Farber Cancer Institute.

FDA OKs COVID-19 Vaccine Booster Shots for Individuals With Weakened Immune Systems

August 13, 2021

Article

The FDA determined that individuals with weakened immune systems — which include patients with cancer — may benefit from a third dose of Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines.

Long-Term Data Show No Survival Benefit Associated With Annual Screening in Women at Low Risk For Ovarian Cancer

August 03, 2021

Article

The results, according to the study authors, demonstrate that screening the general population for tubal and ovarian cancer each year does not result in a survival benefit.

FDA’s Approval of Keytruda-Based Regimen for Certain Stomach Cancer Subtypes ‘Really Exciting’ For Patients

July 23, 2021

Article

The FDA’s recent approval of Keytruda in combination with trastuzumab and chemotherapy in the first-line setting is an exciting change for a group of patients with certain subtypes of stomach cancer, according to an expert.

FDA’s Rybrevant Approval ‘A Step Forward’ For Group of Patients With Non-Small Cell Lung Cancer

July 22, 2021

Article

The FDA’s recent approval of Rybrevant marks the first targeted therapy for a certain group of patients with non-small cell lung cancer, according to an expert at NYU Langone Health’s Perlmutter Cancer Center.

The Toughest Race of His Life

July 09, 2021

Article

More than nine hours of surgery to remove a rare form of bone cancer in the his hip and leg forced Colin Jackson to relearn how to do simple tasks. Months later, he crossed the finish line of a marathon.